Free Trial

60 Degrees Pharmaceuticals (SXTPW) SEC Filings & 10K Form

$0.09
-0.01 (-10.32%)
(As of 11:03 AM ET)

Recent 60 Degrees Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/21/2024
7:22 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:23 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
TOOVEY STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:23 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:18 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
Allen Charles W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:19 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:20 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
FIELD PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
10:56 AM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:19 PM
60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
Form SC 13G/A
04/03/2024
5:00 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
1:32 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/02/2024
2:31 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
2:33 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
11:15 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form EFFECT
01/22/2024
4:01 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
1:56 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
9:29 AM
60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
Form SC 13G
12/18/2023
8:23 AM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2023
11:41 AM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/15/2023
4:14 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form NT 10-Q
10/12/2023
3:17 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:31 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
2:26 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2023
3:08 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
11:37 AM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 424B4
07/12/2023
1:51 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
1:54 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
10:41 AM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form CERT
07/11/2023
11:15 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form EFFECT
07/11/2023
8:21 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
XU CHERYL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:11 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:13 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
Allen Charles W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:16 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
TOOVEY STEPHEN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:18 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
FIELD PAUL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
7:58 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
SMITH BRYAN LEE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:02 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
MILLER TYRONE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:05 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
KENTUCKY TECHNOLOGY INC. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:08 PM
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
Florida State University Research Foundation Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2023
11:51 AM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-A12B/A
06/14/2023
11:22 AM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form 8-A12B/A
06/01/2023
1:53 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form S-1/A
05/24/2023
4:21 PM
60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
This military-backed stock “owns” AI market (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SXTPW) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners